Saturday, June 20, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 886 of 1,261
  1. US 8372979

    Process for the production of high-purity 2,4′-dimethyl-3-piperidino-propiophenone (tolperisone), pharmaceutical compositions that contain the latter, as well as active ingredient formulations that contain tolperisone

    SANOCHEMIA PHARMAZEUTIKA AG · Granted Feb 12, 2013 · Expires Feb 7, 2033

    granted
  2. US 8372843

    Quinolines useful as modulators of ION channels

    Vertex Pharmaceuticals Incorporated · Granted Feb 12, 2013 · Expires Feb 7, 2033

    granted
  3. US 8372802

    Fluorinated macrocyclic compounds as hepatitis C virus inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Feb 12, 2013 · Expires Feb 7, 2033

    granted
  4. DE 102011080389

    Schutzfolienwechsler

    ACINO AG [DE] · Granted Feb 7, 2013 · Expires Feb 2, 2033

    granted
  5. US 8367053

    Cyclosporin analogues

    Enanta Pharmaceuticals, Inc. · Granted Feb 5, 2013 · Expires Jan 31, 2033

    granted
  6. US 8367052

    Methods for promoting protection and regeneration of bone marrow using CXCL9 and anti-CXCL9 antibodies

    GENERAL REGENERATIVES, LTD. · Granted Feb 5, 2013 · Expires Jan 31, 2033

    granted
  7. US 8365314

    Coated elastomeric article and method for making a coated elastomeric article

    Precision Components, Inc. · Granted Feb 5, 2013 · Expires Jan 31, 2033

    granted
  8. US 8367106

    Compressed solid dosage form manufacturing process well-suited for use with drugs of low aqueous solubility and compressed solid dosage forms made thereby

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Feb 5, 2013 · Expires Jan 31, 2033

    granted
  9. US 8367690

    Aminopyridine derivatives having aurora a selective inhibitory action

    Vertex Pharmaceuticals Incorporated · Granted Feb 5, 2013 · Expires Jan 31, 2033

    granted
  10. US 8367841

    Processes for the preparation of 1,2,4-oxadiazole benzoic acids

    PTC THERAPEUTICS, INC. · Granted Feb 5, 2013 · Expires Jan 31, 2033

    granted
  11. US 8367742

    Removable color layer for artificial nail coatings and methods therefore

    Creative Nail Design Inc. · Granted Feb 5, 2013 · Expires Jan 31, 2033

    granted
  12. US 8367810

    Purified plasmodium and vaccine compositions

    Sanaria Inc. · Granted Feb 5, 2013 · Expires Jan 31, 2033

    granted
  13. US 8367401

    Replication competent hepatitis C virus and methods of use

    The Board of Regents of the University of Texas System · Granted Feb 5, 2013 · Expires Jan 31, 2033

    granted
  14. US 8367618

    Cyclosporin analogues for preventing or treating hepatitis C infection

    Enanta Pharmaceuticals, Inc. · Granted Feb 5, 2013 · Expires Jan 31, 2033

    granted
  15. US 8367638

    Galactose-pronged polysaccharides in a formulation for antifibrotic therapies

    GALECTIN THERAPEUTICS, INC. · Granted Feb 5, 2013 · Expires Jan 31, 2033

    granted
  16. US 8366662

    Drug releasing coatings for medical devices

    Lutonix, Inc. · Granted Feb 5, 2013 · Expires Jan 31, 2033

    granted
  17. US 8367734

    Stable epinephrine suspension formulation with high inhalation delivery efficiency

    Amphastar Pharmaceuticals, Inc. · Granted Feb 5, 2013 · Expires Jan 31, 2033

    granted
  18. US 8367120

    Method and apparatus for producing a stablized antimicrobial non-toxic electrolyzed saline solution exhibiting potential as a therapeutic

    Reoxcyn Discoveries Group, Inc. · Granted Feb 5, 2013 · Expires Jan 31, 2033

    granted
  19. US 8367655

    Pyridoindolobenzox—and thiazepine derivatives and uses thereof

    DAYA DRUG DISCOVERIES, INC. · Granted Feb 5, 2013 · Expires Jan 31, 2033

    granted
  20. US 8367660

    Modulators of cystic fibrosis transmembrane conductance regulator

    Vertex Pharmaceuticals Incorporated · Granted Feb 5, 2013 · Expires Jan 31, 2033

    granted
  21. US 8367694

    Carboline derivatives useful in the inhibition of angiogenesis

    PTC THERAPEUTICS, INC. · Granted Feb 5, 2013 · Expires Jan 31, 2033

    granted
  22. US 8367691

    Modulators of muscarinic receptors

    Vertex Pharmaceuticals Incorporated · Granted Feb 5, 2013 · Expires Jan 31, 2033

    granted
  23. US 8367672

    Pyridazine compounds, compositions and methods

    Northwestern University · Granted Feb 5, 2013 · Expires Jan 31, 2033

    granted
  24. US 8367697

    Kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Feb 5, 2013 · Expires Jan 31, 2033

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.